Chronic Heart Failure Clinical Trial
Official title:
Monitoring Electronique à Distance Des Patients Insuffisants Cardiaques
The main objective of the study is to evaluate the effect of telemonitoring on mortality and
rehospitalization due to heart failure on patients with chronic heart failure which have
follow an educational program compared to a conventional follow-up during 1 year.
The secondary objectives of the study are :
- Evaluate the cost of health
- Qualitatively evaluate telemonitoring on uses
- Evaluate quality of life
prospective, monocentric, randomized open-labeled study.
1. - Data collected
1. - during inclusion visit sex, age, full contact details, marital status, number of
child, level of education, professional status weight, height, BMI, cardiac pulse,
blood pressure, NYHA, consumption of tobacco and alcohol, concomitant treatments,
medical history BNP, prealbumin Quality of life questionnaire (Minnesota),
Depression questionnaire (HAD), autonomy questionnaire (IADL)
2. - at 6 month weight, height, BMI, cardiac pulse, blood pressure, NYHA, consumption
of tobacco and alcohol, concomitant treatments, medical history BNP, prealbumin
Number of consultations, nurses care, number of hospitalization in emergency care
unit, number of hospitalization due to acute heart failure, number of days of
hospitalization, number of medical transports Quality of life questionnaire
(Minnesota), Depression questionnaire (HAD), autonomy questionnaire (IADL)
3. - at one year weight, height, BMI, cardiac pulse, blood pressure, NYHA, consumption
of tobacco and alcohol, concomitant treatments, medical history BNP, prealbumin
Number of consultations, nurses care, number of hospitalization in emergency care
unit, number of hospitalization due to acute heart failure, number of days of
hospitalization, number of medical transports Quality of life questionnaire
(Minnesota), Depression questionnaire (HAD), autonomy questionnaire (IADL)
2. - Medico-economic evaluation The objective of this evaluation is to analyzed the
efficiency of telemonitoring in patients with chronic heart failure.
This evaluation has to be :
- quantitative : directs modifications of cost and nature of health care follow-up or
organization
- qualitative : indirect impact on health care costs of situations or behavior
3. - study of uses "uses" is faculty of recognition, comprehension, use, appropriation and
diversion of the telemonitoring by patients.
During the first phase, interviews to obtain qualitative vision of interactions between
telemonitoring and ecosystems of players.
40 qualitative interviews during 2 hours of : 30 patients ; 24 users of telemonitoring and 6
non-users. 10 members of medical and paramedical staff The objectives of the second phase is
to defined usage scenarios from previous assessments.
4.- Telemonitoring surveillance of weight, blood pressure and cardiac pulse, 3 times a week
by the patient at home.
H2AD platform, general practitioner, cardiology unit, therapeutical education team had to
manage alarms.
The devices (balance, blood pressure and pulse monitor) are related by GPRS to a medical
platform. The platform receive every measure of weight, blood pressure and pulse. When
weight, blood pressure or pulse increased or decreased, alarms are emitted and patients are
contacted by a practitioner.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03597646 -
The Effect of Kinesio Taping on Pulmonary Function and Functional Capacity in Patients With Chronic Heart Failure
|
N/A | |
Terminated |
NCT04065997 -
Apogee International
|
||
Withdrawn |
NCT03675113 -
Effect of Upper Extremity Aerobic Exercise Training on Exercise Capacity Patients With Chronic Heart Failure
|
N/A | |
Completed |
NCT02916160 -
Sacubitril-valsartan and Heart Failure Patients : the ENTRESTO-SAS Study
|
Phase 4 | |
Completed |
NCT03126656 -
Effects of Testosterone on Myocardial Repolarization
|
Phase 4 | |
Completed |
NCT02268500 -
VAccination to Improve Clinical outComes in Heart Failure Trial: a Feasibility Study (VACC-HeFT)
|
Phase 4 | |
Completed |
NCT02247245 -
The Influence of Heart Rate Limitation on Exercise Tolerance in Pacemaker Patients.
|
N/A | |
Completed |
NCT01919918 -
Muscle Afferent Feedback Effects in Patients With Heart Failure
|
Phase 1 | |
Terminated |
NCT01906957 -
Cognition and Exercise Training
|
N/A | |
Not yet recruiting |
NCT01669395 -
Severe Heart Failure and Homebased Rehabilitation - An Intersectoral Randomized Controlled Trial
|
N/A | |
Completed |
NCT00984529 -
Evaluation of Clinical Signs and Symptoms of Chronic Heart Failure in Patients Treated With Candesartan Cilexetil in Croatia
|
N/A | |
Recruiting |
NCT00863421 -
Sleep Disordered Breathing in Patients With Chronic Heart Failure
|
N/A | |
Completed |
NCT02840565 -
Tolerability, Pharmacokinetics and Pharmacodynamics of Six Multiple Rising Dose Regimens of BIA 5-453
|
Phase 1 | |
Completed |
NCT02441218 -
Effects of Ivabradine on Cardiovascular Events in Patients With Moderate to Severe Chronic Heart Failure and Left Ventricular Systolic Dysfunction. A Three-year International Multicentre Study
|
Phase 3 | |
Completed |
NCT00149409 -
Omega-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Severe Chronic Heart Failure
|
Phase 2/Phase 3 | |
Terminated |
NCT05532046 -
A Study to Learn How Safe Study Drug BAY2413555 is, How it Affects the Body, and How it Moves Into, Through, and Out of the Body Over 4 Weeks of Use in Participants With Heart Failure and Implanted Cardiac Defibrillator or Cardiac Resynchronization Devices (ICD/CRT)
|
Phase 1 | |
Recruiting |
NCT04984928 -
Readmission Risk of Patients With Heart Failure.
|
||
Completed |
NCT02814097 -
A Study to Evaluate the Effects of 4 Weeks Treatment With Subcutaneous Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Preserved Ejection Fraction
|
Phase 2 | |
Active, not recruiting |
NCT05560737 -
ODYSSEE-vCHAT Mental Health Program for Heart Failure and Kidney Disease Patients
|
||
Recruiting |
NCT03286127 -
Palliative Outcome Evaluation Muenster I
|